Cannabis · CBD — since 2014

Capital finds its way to the institutionalized.

Viridian is the corporate finance, M&A, and strategic advisory practice that has helped build the modern cannabis capital markets. We prepare companies to raise, sell, and scale.

Investment banking services provided through Bradley Woods & Co. Ltd. · Member FINRA / SIPC
Live Deal Tape est. 2015
Premium flower brand, CACapital RaiseAdvised
Cannabis enterprise softwareM&A — Sell-sideAdvised
Licensed medical operator, TXCapital RaiseAdvised
Vertically integrated MSOM&A — Sell-sideAdvised
Cultivation & processing groupM&A — Buy-sideAdvised
CBD consumer brandCapital RaiseAdvised
Cannabis retail chainM&A — Sell-sideAdvised
Premium flower brand, CACapital RaiseAdvised
Cannabis enterprise softwareM&A — Sell-sideAdvised
Licensed medical operator, TXCapital RaiseAdvised
Vertically integrated MSOM&A — Sell-sideAdvised
Cultivation & processing groupM&A — Buy-sideAdvised
CBD consumer brandCapital RaiseAdvised
Cannabis retail chainM&A — Sell-sideAdvised
Illustrative excerpt of Viridian's advisory track record →
$60B+
In deals analyzed since 2015
$2.22B
Deployed in H1 2026
61
H1 2026 transactions
2014
Firm founded
Investors, acquirers, and strategics are increasingly focused on the U.S. cannabis marketplace to deploy capital and build scale. Scott Greiper — Founder & President, Viridian Capital Advisors

Viridian was one of the first dedicated investment banking and advisory practices built for legal cannabis and CBD. We work with operating companies, investors, lenders, buyers, and sellers.

Before a client goes to market, our advisory practice helps "institutionalize" the business: a professional board, defensible financial models, credible valuation work, and a real exit strategy. When it's time to transact, our investment banking practice raises capital and executes M&A through our New York broker-dealer, Bradley Woods & Co. Ltd.

Our Advisory Board draws on decades of senior operating experience from companies including Diageo, Procter & Gamble, Anheuser-Busch, Mars Wrigley, and Condé Nast — brought to bear on cannabis enterprises building for the long term.

Three practices, one desk

Decades of financial experience guide the path from an early-stage business to an institutional one.

Companies
Capital Raise
Equity and debt financing for operating companies scaling cultivation, brands, retail, and technology across cannabis, CBD, and psychedelics.
Tell us your goals →
Buy / Sell
Mergers & Acquisitions
Sell-side and buy-side advisory connecting operators, strategics, and financial buyers to structure and close transactions.
Tell us your goals →
Data driven
Valuation & Strategic Advisory
Board construction, financial modeling, and valuation analysis grounded in our own capital markets data — before you go to market.
Tell us your goals →

Selected transactions

A sample of engagements across capital raising and M&A.

Capital Raise
Exclusive placement agent
Leading premium flower brand, California
View transaction →
M&A — Sell-side
Exclusive M&A advisor
Leading cannabis enterprise software company
View transaction →
Capital Raise
Exclusive banker & advisor
One of three licensed medical cannabis operators, Texas
View transaction →
M&A — Sell-side
Exclusive advisor to the seller
Regional cultivation & retail operator
View transaction →
Strategic Advisory
Board & capital structure
Multi-state vertically integrated operator
View transaction →
M&A — Buy-side
Exclusive advisor to the acquirer
Multi-state cannabis brand portfolio
View transaction →

Research reports

Quarterly and semi-annual reads on cannabis capital markets, drawn from Viridian's proprietary deal database.

Quarterly Report

Cannabis Deal Tracker — Q1 2026

$1.97B
Capital deployed
40
Total deals
20
M&A deals

A full breakdown of Q1 2026 M&A, equity, and debt activity — including the sector's post-rescheduling-optimism refinancing wave and a look ahead to Q2.

Download PDF →
Semi-Annual Review

Cannabis Deal Tracker — First Half 2026

$2.22B
Capital deployed
61
Total deals
32
M&A deals

A comprehensive H1 2026 review covering the Schedule III reclassification, the Q1 refinancing surge, and a quieter Q2 as operators awaited the June DEA hearing.

Download PDF →

Testimonials

2022 Benzinga Cannabis Award

Best Investment Research — "Viridian has collected and aggregated the world's largest database of cannabis deals." — Benzinga

"The Viridian team was by our side throughout the capital raise process and helped us source and negotiate the optimal debt financing. The market intelligence from the Viridian Cannabis Deal Tracker was instrumental in negotiating the best transaction."

Ryan JennemanCEO, THC Design

"We especially want to thank the team at Viridian Capital for their sage counsel on valuation and deal structures throughout the M&A process that helped guide us to a successful close."

Jordan WeissCEO, Green Coast Hydroponics

"We thank Scott Greiper and his team at Viridian Capital for their guidance and perseverance in completing our Series A and Series B financings. Data from the Deal Tracker guided us in understanding our value and the optimal deal structure."

Morris DentonCEO, Texas Original

Recent events & webinars

Viridian is consistently asked to speak at, and co-host, some of the industry's most attended conferences and webinars.

Marijuana Business Daily Annual Conference
Scott Greiper keynoted the "M&A in Cannabis" session
Keynote
Benzinga Annual Cannabis Capital Conference — New York City & Florida
Scott Greiper keynoted "Cannabis M&A Challenges and Opportunities"
Keynote
Cannabis Investing Outlook
Hosted by Viridian Capital and Foley & Lardner LLP
Co-hosted
M&A in Cannabis Webinar
Hosted by Viridian Capital and Dentons
Co-hosted
The Rise of SPACs as Acquirors in the Cannabis Industry
Hosted by Viridian Capital and OTC Markets Group
Co-hosted
Restructuring for Success in the Cannabis and Hemp Industry
Hosted by Viridian Capital and Foley & Lardner LLP
Co-hosted
Benzinga Virtual Conference: Key Drivers of Capital in Cannabis
Scott Greiper was the keynote speaker for this MJ Biz webinar
Keynote
CBD Brand Opportunities Investor Pitch Competition
Scott Greiper represented Viridian as an Investor Judge
Virtual

Viridian's media coverage

The Wall Street Journal Forbes Bloomberg CNBC Reuters USA Today The Economist Barron's
Fortune CNN Money TheStreet U.S. News & World Report Entrepreneur S&P Global Market Intelligence Institutional Investor Crain's Silicon Valley MainStreet Investopedia Benzinga Private Wealth Vice Leafly Axial Forum LA Weekly Marijuana Business Daily Playboy Weedmaps The Cannabist Black Enterprise High Times MSN Money Metro Motherboard Cannabis News Florida South Florida Times CannaInvestor Magazine Florida Politics Jewish Business News Mattermark York Dispatch

Ready to participate in one of the fastest-growing industries?

Investors

Deploy capital

Get access to vetted opportunities across cannabis, CBD, and psychedelics.

Tell us your goals
Companies

Raise capital

Prepare your business and go to market with an institutional-grade process.

Tell us your goals
Buy or sell

Mergers & acquisitions

Work with a desk that has helped link buyers and sellers across the industry.

Tell us your goals